TNFRSF4 and neoplasm: Verbrugge et al. (2012) demonstrated that local RT combined with anti-OX40 could mediate significant growth delay of orthotopic AT-3 mammary tumors, however, the addition of anti-PD-L1 was required to mediate complete tumor regression.